Supplementary Figure 4 from BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Figure 4. Combination of copanlisib and navitoclax does not significantly alter the RAS/RAF pathway.
Authors: Rebecca A. DeStefanis, Alexa E. Schmitz, Alyssa K. Steimle, Susan N. Payne, Gioia C. Sha, Autumn M. Olson, Alec Cornelio, Anna E.L. Lippert, Sean G. Kraus, Katherine A. Johnson, Peter F. Favreau, Amani Gillette, Christopher Babiarz, Devon Miller, Carley M. Sprackling, Cheri A. Pasch, Stephanie Pritzl, Dana R. Van De Hey, Demetra P. Korkos, Tyler M. Foley, Alexander E. Yueh, Aurora L.J.X. Greane, Linda Clipson, Melissa C. Skala, Dustin A. Deming
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4416903209